RTOG Foundation   Report issue

Foundation Phase 1 Phase 2 Phase 3
Founded: Philadelphia PA United States (1997)

Organization Overview

First Clinical Trial
2016
NCT02764593
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

RTOG Foundation | RTOG Foundation, Inc.